The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 19,240 | 2,600,014 | SH | SOLE | 2,600,014 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 15,025 | 1,312,258 | SH | SOLE | 1,312,258 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 36,350 | 1,887,332 | SH | SOLE | 1,887,332 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 5,978 | 950,366 | SH | SOLE | 950,366 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | COM | 53619R102 | 17,178 | 2,087,281 | SH | SOLE | 2,087,281 | 0 | 0 | ||
| PRONAI THERAPEUTICS INC | COM | 74346L101 | 3,979 | 2,186,195 | SH | SOLE | 2,186,195 | 0 | 0 | ||
| TOBIRA THERAPEUTICS INC | COM | 88883P101 | 106,049 | 2,668,570 | SH | SOLE | 2,668,570 | 0 | 0 | ||